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Table
Characteristics and Outcomes
Characteristic
Patients
at 3
months
< 80%
Donor
in PB
> 80%
Donor
in PB
P-
value
Number of patients 96 64 32
Age, median (range) yrs 55.1
(18-72)
55.3
(19-72)
51.5
(18-67)
Age, mean (SD) yrs 53 54.2 50.8 0.24
Disease at transplantation, no.
MDS (22%) 21 15 6 0.32
AML (55%) 53 36 17
CML (7%) 7 5 2
ALL (13%) 12 5 7
Other (3%) 3 3 0
Donor/recipient sex, no.
Male/ male (36%) 35 23 12 0.22
Male/ female (26%) 25 17 8
Female/ male (19%) 18 15 3
Female/ female (19%) 18 9 9
Donor type, no.
HLA-identical related (47%) 45 33 12 0.21
HLA-matched unrelated (33%) 32 20 12
HLA-mismatched
unrelated (20%)
19 11 8
Conditioning regimen, no. (All
patients received ATG)
TBI Thio Cy/Flu (34%) 33 21 12 0.57
Clo Mel Thio (7%) 7 4 3
Bu Mel Flu (58%) 56 39 17
Source of stem cells, no.
Bone marrow (3%) 3 2 1 NA
PBSC (97%) 93 62 31
Acute GVHD, grades II-IV 13 6 7 0.12
Deaths, no. 32 11 21
Organ Failure 0 1
Infection 2 4
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Introduction: Chronic iron (Fe) overload represents
a serious threat to patients undergoing allogeneic trans-
plants and is associated with increased morbidity and
mortality. The effects Fe overlaod on immune function is
largely unknown and not studied in this population.
Patients: The study was conducted at the Comprehensive
Center of Wake Forest University (CCCWFU) in patients (pts)
with transfusional Fe overload. All pts had received alloge-
neic transplants for treatment of hematological disorder.The
eligible study participants underwent assays for 16 serum
cytokines, lymphocyte subtypes, and neutrophil function to
assess cellular immune function before and after chelation.
We then assessed cytokine production in response to lipo-
polysaccharide (LPS) in mononuclear cell culture from four
additional pts and healthy controls.
Methods: Iron overload was deﬁned as 1) serum ferritin >
1,000 ng /mL; 2) >25 transfusions; and 3) marrow Fe stain of
6+. Baseline MRI of heart and liver were performed for
conﬁrmation of Fe overload. We enrolled 4 pts prior to
receiving chelation. Patients underwent chelation with
deferasirox (Exjade) for six months. Co-morbidities and
microbial and infection data were collected. We examined
respiratory burst of neutrophils before and after ex vivo
stimulation, lymphocyte subtypes, and serum levels of 16
cytokines, assessed before and after chelation paired with
four healthy controls. A follow-up study enrolled four addi-
tional patients with Fe overload before chelation therapy.
Mononuclear cells were collected from pts and healthy
control subjects and cultured for 48 hrs in the presence or
absence of LPS. Media was collected and assessed for 16
cytokines in a multiplex assay.
Results: The patients had marked improvement in overall
functional as well as hospitalization due to infection during
the study period while on chelation. However, no differences
were observed in serum cytokine levels, lymphocyte proﬁles,
or neutrophil respiratory burst before and after chelation.In
a follow-up preliminary study, cultured mononuclear cells
from patients with Fe overload had statistically signiﬁcant
log increases in the levels of TNFa (P ¼ .0004) and IL-6
(P ¼ .0004) secreted in response to LPS.All eight patients had
polymicrobial infections prior to chelation.
Conclusion: The increased susceptibility to unusual infec-
tions may be related to abnormally high iron in macro-
phages. The increase in TNF a and IL-6 in mononuclear cells
(presumably produced by monocytes/macrophages) before
chelation is suggestive of intracellular Fe overload corre-
lating with increased susceptibility to infection. This pilot
study has limitations due to small sample size. Future studies
involving a large cohort of patients would help us under-
stand the effect of iron overload on monocyte/macrophage
function and also impact of chelation to improve co-
morbidities related to infection.GVHD 1 (post-DLI) 3
Graft Failure 1 0
Relapse 6 10
Other 1 2
Outcomes at 2 yrs.
Relapse 24% 19% 0.70
NRM 3% 26% 0.001
DFS 61% 53% 0.22
OS 79% 51% 0.01384
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Background: The impact of mixed chimerism (MC) in
peripheral blood (PB) after myeloablative unmodiﬁed SCT is
controversial. There are limited reports on the signiﬁcance of
MC after T-cell depleted (TCD) SCT. This study was under-
taken to evaluate the impact of 3month PB Tcell MC (deﬁned
as < 80% donor) on outcomes at 2 yrs post-TCD SCT.
Methods: A retrospective review was conducted on adult
patients who underwent TCD bone marrow (BM) or
peripheral blood stem cell (PBSC) SCT from 1/2008-6/2011.
PB chimerism (using short tandem repeat analysis on the T
cell (TC) population) and disease status by BM evaluation
were performed at 3, 6, 12, 18 and 24 months. No patient
received a donor lymphocyte infusion (DLI) prior to 3 month
landmark. Those who received DLI post-landmark were
censored at time of DLI (N¼15). Patient and SCT character-
istics were compared using Wilcoxon's rank-sum test/
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(OS) were estimated using Kaplan-Meier methods, and time-
to-relapse and non-relapse mortality (NRM) were estimated
using cumulative incidence functions. Cox regression was
used to further investigate the association between chime-
rism and the risk of NRM adjusted for key covariates.
Results: Of 161 patients identiﬁed, 96 were disease free and
had PB TC chimerism at 3 month Table 1 lists transplant
characteristics and outcomes. PB TC MC was observed in 64
(66%) at 3 month There was no difference in chimerism
based on disease, stem cell source, HLA-match, donor-
recipient gender pairing, or conditioning regimen. Relapse
and DFS were not different between the MC and full donor
chimerism groups. However, NRM was signiﬁcantly higher
(P-value 0.001) and OS was signiﬁcantly lower (P-value 0.01)
in the full donor chimerism group at 2 years. Using Cox
regression, the association between chimerism and NRM
remained after adjusting for DLI, disease, conditioning
regimen and donor-recipient sex (P value 0.03). Analysis of 6
month PB TC chimerism also showed patients withMC in the
PB at 6 months had less NRM and improved OS than patients
with full donor chimerism.
Conclusions: In this analysis of PB TC chimerism following
TCD transplant, both NRM and OSwere signiﬁcantly better in
patients with MC. These data suggest that DLI for the
conversion of MC to full chimerism may be unnecessary.385
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Intraduodenal haematoma (IDH) has been noted usually
after blunt abdominal trauma. It has been recognized as
a complication of endoscopic biopsy and the risk is high in
patients with bleeding disorders. History of bone marrow
transplantation seems tobe relevant risk factor. The incidence
is estimated to be 1/1250 upper gastrointestinal endoscopies.
The diagnosis is likely if symptoms of acute abdominal pain
and vomiting occur within 48 hours after duodenal biopsy.
The symptoms are usually caused by duodenal obstruction.
Pancreatitis may develop. Conservative management is the
preferred approach if perforation is excluded. Complete
resolution generally occurs within 2-3 weeks.
A-18-year old girl with acute lymphoblastic leukemia
underwent allogeneic peripheral blood stem cell trans-
plantation. Diarrhea developed on the third month and
gastrointestinal endoscopic biopsies were performed for
GVHD evaluation. The mucosa of stomach was reddish and
edematous but other parts looked normal. Three hours later
the patient had severe vomiting, intense abdominal tender-
ness and massive haematemesis which required red cell
transfusions. A second look revealed active hemorrhage from
biopsy side at the cardioesophageal junction. Epinephrine
injectionwas performed and the clinical status was related to
Mallory-Weiss tear due to severe vomiting. However her
complaints persisted despite full supportive treatment.Abdominal CT scan revealed a 9 cm mass with diameter of 5
cmwithin the second and third duodenal portions consistent
with an intramural haematoma. There was also hemoper-
itoneum. Since perforation was excluded conservative
management was initiated including bowel rest, parenteral
nutrition and nasogastric decompression. On day 14 serum
bilirubin levels reached 7.5 mg/dl with GGT:393 U/L, ALP:329
U/L values. MRI revealed 8x4 cm haematoma compressing
the ampulla of Vater. She improved in the following days.
Haematoma regressed to 3 cm on the 4th week and the
patient was discharged.
In our patient blood counts and coagulation tests were
within normal limits at the time of endoscopic intervention.
Biopsies were consistent with GVHD and the mucosal
damage caused by this condition may have been contributed
to duodenal vulnerability. Depending on other reported
cases with bone marrow transplantation we can conclude
that endoscopic interventions should be carefully employed
in this subgroup of patients.386
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BKVN is reported in 8% of renal transplant (RT) patients
(pts) and leads to renal failure/graft loss if untreated. In HSCT
BKV is mainly associated with hemorrhagic cystitis (HC),
with few BKVN cases reported to-date. In RT, treatment (tx)
is primarily immunosuppression reduction, not feasible in
HSCT due to the risk of graft versus host disease (GvHD). IV
cidofovir (CDV) is used as adjunctive tx, but is associated
with signiﬁcant nephrotoxicity. At MSKCC, we have had 5
HSCT pts with tissue-proven BKVN in past 6 yrs. Diagnosis
(dx) was by biopsy in 2, autopsy in 2 and nephrectomy in 1.
Three pts received T‑cell depleted (TCD) grafts, 3 had GvHD
and 3 CMV disease. Three had severe HC with clot obstruc-
tion. Two pts developed end-stage renal disease (ESRD)
requiring hemodialysis (HD) despite tx with CDV. ESRD
preceded the BKVN dx. We present 1 HSCT pt treated for
BKVNwith CMX001 in an open-label, expanded access study
(CMX001-350; ClinicalTrials.gov ID: NCT01143181). CMX001
is an orally bioavailable, broad spectrum, lipid acyclic
nucleoside phosphonate converted intracellularly into the
active antiviral CDV. The pt (58 YO white male) with history
of chronic lymphocytic leukemia/small lymphocytic
lymphoma (SLL) transformed to a diffuse, large B-cell
lymphoma received a TCD graft from a matched, unrelated
donor. He had SLL relapse +6 mos post-HSCT (tx with
chemotherapy, donor lymphocyte infusion and lenalido-
mide), complicated by grade IV steroid-refractory acute
